gadolinium dtpa has been researched along with Chronic Progressive Multiple Sclerosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freedman, MS; Hii, M; Kang, H; Kolind, S; Le, M; Li, DKB; Riddehough, A; Tam, R; Traboulsee, A | 1 |
| Bellmann-Strobl, J; Brandt, AU; Chien, C; Dörr, J; Paul, F; Scheel, M; Schlemm, L; Wuerfel, J | 1 |
| Altmann, D; Ciccarelli, O; Khaleeli, Z; Miller, DH; Mizskiel, K; Thompson, AJ | 1 |
| Andrews, M; Brooks, CL; Dolic, K; Dwyer, MG; Hojnacki, DW; Hunt, K; Kennedy, CL; Lopez-Soriano, A; Magnano, CR; Reuther, JA; Schirda, CV; Weinstock-Guttman, B; Zivadinov, R | 1 |
| Ekholm, S; Liu, X; Rao, P; Segal, BM; Tian, W; Zhong, J; Zhu, T | 1 |
| Filippi, M; Iozzelli, A; Losacco, C; Murialdo, A; Sardanelli, F | 1 |
| Beliaeva, IA; Boĭko, AN; Gusev, EI; Kornienko, VN; Pronin, IN | 1 |
| Comi, G; Filippi, M; Inglese, M; Mancardi, GL; Murialdo, A; Pagani, E; Rocca, MA; Saccardi, R | 1 |
| Filippi, M; Mancardi, G; Sardanelli, F | 1 |
| Galassi, W; Hesselink, JR; Laopaiboon, M; Laopaiboon, V; Phuttharak, W | 1 |
| Altmann, D; Miller, D; Soon, D; Tofts, P; Tozer, D | 1 |
| Adèr, HJ; Barkhof, F; Castelijns, JA; Jongen, PJ; Lycklama A Nijeholt, GJ; Polman, CH; van Walderveen, MA | 1 |
| Filippi, M; Good, CD; MacManus, DG; Miller, DH; Silver, NC; Sormani, MP; Thompson, AJ | 1 |
3 trial(s) available for gadolinium dtpa and Chronic Progressive Multiple Sclerosis
| Article | Year |
|---|---|
Three subsequent single doses of gadolinium chelate for brain MR imaging in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Observer Variation; Sensitivity and Specificity | 2003 |
Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation.
Topics: Artifacts; Atrophy; Brain; Contrast Media; Follow-Up Studies; Gadolinium DTPA; Hematopoietic Stem Cell Transplantation; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Multiple Sclerosis, Chronic Progressive | 2004 |
Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes.
Topics: Adult; Blood Volume; Blood-Brain Barrier; Disability Evaluation; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Models, Biological; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Sensitivity and Specificity | 2007 |
10 other study(ies) available for gadolinium dtpa and Chronic Progressive Multiple Sclerosis
| Article | Year |
|---|---|
Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast Agents.
Topics: Brain; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Neuroimaging; Retrospective Studies | 2018 |
Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
Topics: Adult; Cerebellar Nuclei; Contrast Media; Databases, Factual; Female; Gadolinium DTPA; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Tissue Distribution | 2017 |
Lesion enhancement diminishes with time in primary progressive multiple sclerosis.
Topics: Adult; Aged; Brain; Contrast Media; Disability Evaluation; Disease Progression; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Linear Models; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Predictive Value of Tests; Risk Assessment; Risk Factors; Spinal Cord; Time Factors; Young Adult | 2010 |
Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects.
Topics: Adolescent; Adult; Case-Control Studies; Contrast Media; Face; Female; Gadolinium DTPA; Humans; Imaging, Three-Dimensional; Jugular Veins; Magnetic Resonance Angiography; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neck; Prospective Studies; Reproducibility of Results; Statistics, Nonparametric | 2011 |
Progressive decline in fractional anisotropy on serial DTI examinations of the corpus callosum: a putative marker of disease activity and progression in SPMS.
Topics: Analysis of Variance; Anisotropy; Case-Control Studies; Contrast Media; Corpus Callosum; Diffusion Tensor Imaging; Disease Progression; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Statistics, Nonparametric | 2012 |
[Diagnostic and prognostic potential of MRI in multiple sclerosis].
Topics: Adult; Brain; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Prognosis | 2003 |
Safety of the long-time monthly triple dose of a Gd-based contrast agent.
Topics: Adult; Cohort Studies; Contrast Media; Female; Gadolinium DTPA; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Longitudinal Studies; Male; Multiple Sclerosis, Chronic Progressive; Safety | 2003 |
ADC measurements in various patterns of multiple sclerosis lesions.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Confidence Intervals; Diffusion Magnetic Resonance Imaging; Disability Evaluation; Disease Progression; Echo-Planar Imaging; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sex Factors; Statistics, Nonparametric | 2006 |
Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
Topics: Adult; Age Factors; Axons; Brain; Contrast Media; Cross-Sectional Studies; Disability Evaluation; Disease Progression; Echo-Planar Imaging; Female; Gadolinium DTPA; Humans; Linear Models; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Severity of Illness Index; Sex Factors; Surveys and Questionnaires | 2001 |
A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis.
Topics: Adult; Blood-Brain Barrier; Brain; Clinical Trials as Topic; Contrast Media; Cross-Over Studies; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Single-Blind Method; Spinal Cord; Statistics, Nonparametric | 2001 |